Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever

Tropical Doctor

Volumn 39, Issue 3, 2009, Pages 158-160

  Fisgin, Nuriye Tasdelen ^a   Tanyel, Esra ^a   Doganci, Levent ^a   Tulek, Necla ^a  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONGO; CONTROLLED STUDY; HEMORRHAGIC FEVER; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MORTALITY; NAIRO VIRUS; PARTIAL THROMBOPLASTIN TIME; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL RATE; THROMBIN TIME; THROMBOCYTE COUNT;

FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; PLATELET COUNT; PROTHROMBIN TIME; RISK FACTORS;

EID: 67650386232     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/td.2008.080092     Document Type: Article

References (10)

1. Tasdelen Figsin N, Fisgin T, Tanyel E, et al., Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome. Am J Hematol, 2008;83:73-6
2. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis, 2006;6:203-14
3. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis, 2004;39:284-7
4. Karti SS, Odabasi Z, Korten V, et al., Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis, 2004;10:1379-84
5. Bakir M, Ugurlu M, Dokuzoguz B, et al., Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol, 2005;54:385-9
6. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect, 2006;12:551-4
7. Ozkurt Z, Kiki I, Erol S, Erdem et al., Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect, 2006;52:207-15
8. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res, 2004;64:145-60
9. Schwarz TF, Nsanze H, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection, 1997;25:364-7
10. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis, 1989;11:794-800